Peptide and use therefor
AssigneeNiigata University
InventorsEisaku Kondo, Ken Saito
Life of this patent
Estimating the term…
Loading patent…
AssigneeNiigata University
InventorsEisaku Kondo, Ken Saito
Estimating the term…
This peptide is composed of an amino acid sequence represented by general formula (I), and has a high degree of accumulation in cancer cells or cancer tissue in a digestive system. In general formula (I), X11 is a peptide residue composed of an amino acid sequence of (a) or (b) below: (a) an amino acid sequence represented by any of SEQ ID NOs: 1 to 3, (b) an amino acid sequence including a sequence in which one or two amino acids have been deleted, substituted or added in an amino acid sequence represented by any of SEQ ID NOs: 1 to 3; Y11 is a peptide linker composed of an amino acid residue of at least 1 but not more than 10 amino acids, wherein each amino acid residue is independently a glycine residue, a proline residue, a serine residue, a cysteine residue or a lysine residue; X12 is either a peptide residue composed of an amino acid sequence of (a) or (b) above, or a retro-inverso peptide residue thereof; and n11 represents an integer of at least 1 but not more than 9. X11—(Y11—X12)n11 General formula (I):
A peptide composed of an amino acid sequence represented by general formula (I) shown below, and having a high degree of accumulation in cancer cells or cancer tissue in a digestive system:
Dependencies are inferred from the claim text.